Key Industry Insights and Findings from the Nicotine Replacement Therapy Market Report

According to the analysis shared by our research analysts, the nicotine replacement therapy market is expected to grow at a CAGR of around 15.1% annually (2022-2028).

The nicotine replacement therapy market was determined to be worth approximately $44.5 billion in 2021 through preliminary research and is expected to reach approximately $103.4 billion by 2028.

The prevalence of smoking-related diseases and increasing government measures to support smoking, as well as increasing acceptance of e-cigarettes and heated tobacco are expected to favorably impact the development of the North American market.

· The number of smokers complying with smoking bans in the region is on the rise, leading to stronger demand for products such as chewing gum and inhalers. In addition, smoking cessation rates in the United States are higher than in other countries, which has led to an increase in sales of these goods.

According to a survey conducted by the Centers for Disease Control and Prevention (CDC), about 68 percent of Americans have decided to quit smoking. Hence, this is expected to increase product sales in the coming years.

A major factor driving the growth of the global nicotine replacement therapy market is the rising awareness of smoking globally.